224 results on '"Buadi, F K"'
Search Results
2. Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival
3. Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category
4. Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival
5. Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
6. The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents
7. Autologous stem cell transplant for multiple myeloma patients 70 years or older
8. Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents
9. Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment
10. Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma
11. Natural history of t(11;14) multiple myeloma
12. Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma
13. Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy
14. Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy
15. Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma
16. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
17. Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy
18. Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy
19. Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma
20. Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.
21. Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis
22. Second auto-SCT for treatment of relapsed multiple myeloma
23. Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies
24. Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006
25. SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization
26. Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma
27. Impact of early relapse after auto-SCT for multiple myeloma
28. Impact of additional cytoreduction following autologous SCT in multiple myeloma
29. Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT
30. Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma
31. Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma
32. Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma
33. Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization
34. Multiple myeloma with concomitant JAK2-positive essential thrombocythemia post-successful autologous peripheral blood hematopoietic stem cell transplant
35. Systemic amyloidosis from A (AA) to T (ATTR): a review
36. Relevance of Conventional Prognostic Factors in Multiple Myeloma (MM) in the Era of Novel Therapies: A366
37. Systemic amyloidosis from A (AA) to T (ATTR): a review.
38. Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation
39. Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains
40. Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial
41. Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
42. Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation
43. Natural history of t(11;14) multiple myeloma
44. Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis
45. Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma
46. Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era
47. Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category
48. The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents
49. Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
50. Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.